PPARA and metabolic dysfunction-associated steatohepatitis: In addition, pan PPAR-iMSC-EVs stimulated the PI3K-AKT pathway in steatotic human primary hepatocytes, and a higher number of proliferating hepatic cells were observed in pan PPAR-iMSC-EVs-treated NASH mice.